Access to Genetic Testing in Underserved Patients With Cancer
Recruiting · NCT06422455 · Interventional (participants receive a specific treatment) · Lead sponsor: University of Southern California
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
This study compares the experiences of people who receive information about genetic testing from a computer-generated character to patients who receive information from a human genetics healthcare provider. Patients with cancer are increasingly recommended for genetic testing as standard of care. Multiple factors contribute to low usage of genetic testing but for many patients the lack of access to genetic counseling and testing is an important and flexible factor. Lack of access is especially relevant to racial/ethnic minority patients and those living in non-metropolitan rural settings who are frequently cared for at safety-net hospitals with limited genetics services. Alternative delivery models are necessary to improve rates of access to genetic testing in patients with cancer. Health information technology is under used by genetics providers. A patient-facing relational agent (PERLA) will provide pre-test genetics education in both English and Spanish across two clinical settings to facilitate more timely access to genetic testing. Using the PERLA intervention may help researchers learn different ways to provide education about genetic testing to patients with cancer compared to usual care.
Who can take part
Inclusion criteria
- Age \> 18 years old
- Diagnosed with least one of the following:
- Epithelial ovarian cancer
- Exocrine pancreatic cancer
- Metastatic or high or very high-risk prostate cancer
- Breast cancer at or before age 50
- Bilateral breast cancer
- Triple negative breast cancer
- Male breast cancer OR
- Healthcare provider who treats patients with any of the above types of cancer
- Able to read and write in English or Spanish
- Able to provide informed consent
Exclusion criteria
- Patients who cannot provide informed consent
- Patients who cannot see, read, or write
- Patients who have the cancer and clinical characteristics defined in the inclusion criteria, but who do not speak English or Spanish
- Patients with none of the listed cancer diagnoses and clinical characteristics
- Healthcare provider who do not treats cancer patients
Where it is running
4 locations listed across 2 US states.
- USC / Norris Comprehensive Cancer Center - Los Angeles, California, United States
- USC / Norris Comprehensive Cancer Center - Los Angeles, California, United States
- University of Rochester - Rochester, New York, United States
- University of Rochester - Rochester, New York, United States